Study Links VPS25 Gene to Newborn Brain Disorder

Researchers report the first evidence tying changes in the VPS25 gene to a human disease affecting children's brains.

Updated on Nov. 16, 2026 in Life Sciences

Study Links VPS25 Gene to Newborn Brain Disorder

Researchers published a Genome Medicine study on September 14, 2026, identifying a genetic cause for a severe newborn brain disorder that had remained unexplained. The study examined five unrelated families across Saudi Arabia, Europe, and North America whose children showed similar symptoms and changes in the same gene.

Why it matters

For families whose children were affected, the findings offer an explanation where none previously existed. The discovery may also allow the condition to be detected through genetic testing during pregnancy and help identify additional cases worldwide.

The evidence is a genetic case series of five unrelated families across Saudi Arabia, Europe, and North America, with three families first identified through Saudi genomic programs. Researchers have not yet established how the condition varies between children or how many additional cases exist worldwide.

The players

King Faisal Specialist Hospital and Research Center

A major tertiary hospital and research institution in Riyadh, Saudi Arabia, known for its clinical genetics and specialty care programs.

King Abdullah University of Science and Technology

A graduate research university in Thuwal, Saudi Arabia, known for its work in genomics, biosciences, and other applied sciences.

Genome Medicine

A peer-reviewed journal published by BioMed Central that focuses on genomics research with clinical and biomedical relevance.

The details

The children from the five families had similar symptoms and changes in the VPS25 gene, which plays a role in maintaining nerve cells. Laboratory testing showed disruptions that altered the number and contents of tiny packages released by cells, with some missing proteins involved in protecting nerve cells. Clinicians at King Faisal Specialist Hospital and Research Center documented the symptoms, while King Abdullah University of Science and Technology researchers studied the underlying cellular problems.

Timeline

  1. September 14, 2026: Genome Medicine published the study linking VPS25 changes to the brain disorder.

Health Landscape

The study follows the family-based gene discovery approach that became central to rare pediatric disease research in the 2010s, when unrelated families with matching symptoms were used to pinpoint single causal genes. Connecting cases across Saudi Arabia, Europe, and North America extends that method to a condition that had lacked any known genetic explanation.

The most immediate practical effect is the possibility of genetic testing during pregnancy for families with a history of this condition. Over time, identifying the VPS25 gene may help clinicians recognize cases earlier and guide families toward more informed decisions about their care.

The takeaway

A single shared gene can explain a condition that once seemed mysterious, and connecting cases across borders can make that discovery possible. Families facing unexplained neurological symptoms in their children may benefit from asking whether genetic testing is available.

Further reading

For broader context on how gene discoveries like this are made, explore the Life Sciences section.

Source note: This article includes information reported by SciTechDaily.